You are here: Home » 0 » » Archives for 0st

Florida-Based Cybersecurity Company Launches Australian Data Centre

Sydney, March 25, 2024 (GLOBE NEWSWIRE) — Leading cybersecurity solution provider, ThreatLocker, proudly announces the launch of its advanced data centre in Sydney, Australia, just over a year after the grand opening of its second headquarters in Dublin, Ireland. This strategic move aims to enhance cybersecurity capabilities across various sectors in Australia, including the private sector, commonwealth, state, territory, and local governments. 

The expansion of ThreatLocker will assist Australian entities in complying with the urgently recommended Australian Cyber Security Strategy implemented by the Australian Government. Additionally, ThreatLocker offers Zero Trust Application Controls and Ringfencing capabilities that align almost any organization with requirements presented by the Australian Cyber Security Centre’s Essential Eight Maturity Model. 

Commenting on the extension of their security footprint, ThreatLocker Chief Executive Officer and Co–Founder Danny Jenkins said, “Zero Trust is a mindset, and I admire the Australian government's holistic approach, involving the wider community to tackle a modern–day threat.” 

Jenkins continued, “As one of the top vendors assisting businesses with Essential Eight guidelines, we are thrilled to strengthen our collaboration with Australia through this centre, bolstering their data protection and compliance initiatives.” 

ThreatLocker, founded in 2017 by CEO Danny Jenkins, COO Sami Jenkins, and VP of Quality Assurance John Carolan, protects over 2 million endpoints across more than 40,000 organizations globally. The company provides 24/7/365 support with an average response time of 60 seconds or less. ThreatLocker offers a powerful Zero Trust endpoint protection platform that enables organizations to stop ransomware and other cyberattacks by controlling what software can run in their environments. The combined solutions of ThreatLocker, including Application Allowlisting, Ringfencing™, Storage Control, Elevation Control, and Endpoint Network Control, lead the cybersecurity market toward a more secure approach by blocking the exploits of unknown application vulnerabilities. 

Attachment


GLOBENEWSWIRE (Distribution ID 9067557)

To Bolster Global Efforts in Combating Antibiotic-Resistant Bacteria KFSH&RC Scientists Discover New Bacteria Species: Riyadhensis

RIYADH, Saudi Arabia, March 25, 2024 (GLOBE NEWSWIRE) — In a ground–breaking development, scientists at King Faisal Specialist Hospital and Research Centre (KFSH&RC) have identified a new species of bacteria, referred to as “Stenotrophomonas Riyadhensis” through the application of whole–genome sequencing (WGS) technology. This discovery signifies a major advancement in understanding how bacteria interact with existing drugs, paving the way for innovative therapeutic strategies. Such efforts are essential in the global fight against antibiotic–resistant bacteria, highlighting KFSH&RC’s advanced research capabilities and its leading role in fostering scientific discoveries and enhancing patient care.

The discovery of “Riyadhensis” reinforces the potential of genomic tests in innovating promising diagnostic and therapeutic methods, as well as deepening the understanding of bacterial resistance mechanisms, particularly in sensitive environments like intensive care units (ICU) and among patients with compromised immune systems. This represents substantial progress in combating antibiotic resistance, developing pharmaceuticals, and preventing the spread of diseases.

This newly identified bacteria was discovered amid an in–depth investigation into a suspected outbreak in the ICU of KFSH&RC in 2019, highlighting challenges previously unrecognized by the global scientific and medical communities in pinpointing and countering new bacterial strains. Initially thought to be a variant of Pseudomonas aeruginosa, a disease–causing bacterium known for its resistance to antibiotics, subsequent WGS analysis revealed it did not share the common characteristics of the Pseudomonas genus. Instead, Riyadhensis was found to belong to the Stenotrophomonas family, with a unique genetic composition and morphological traits, unlike any other scientifically recognized members.

Dr. Ahmad Al Qahtani, Head of the Infectious Disease and Immunity Department at The research center of KFSH&RC stated: “Traditional bacterial identification methods may lead to misidentification, in contrast, WGS analysis offers a precise and targeted approach that ensures accurate identification and provides detailed insights into resistance mechanisms, proving its significance in disease outbreak investigations and patient care improvements.”

Dr. Reem Almaghrabi, Head of Transplant Infectious Diseases at the Organ Transplant Centre of Excellence at KFSH&RC highlighted the discovery’s importance in advocating for continuous monitoring and the use of advanced technologies like WGS in developing faster and more accurate diagnostic methods. Furthermore, this approach lays the groundwork for scientific collaboration at all levels, enhancing global efforts to combat antibiotic resistance.

Understanding the nuances of new bacterial species, particularly their antibiotic resistance, is crucial in modern healthcare and serves as the primary means of combating bacterial infections. As these bacteria continuously evolve their resistance, they pose a significant and ongoing threat to human health.

It is noteworthy that KFSH&RC has been ranked first in the Middle East and Africa, and 20th globally, in the list of the top 250 healthcare institutions worldwide for the second consecutive year, according to the 2024 Brand Finance rankings. Additionally in the same year, it was ranked among the world's best hospitals by the prestigious Newsweek magazine.

King Faisal Specialist Hospital & Research Centre stands among the global leaders in providing specialized healthcare, driving innovation, and serving as an advanced hub for medical research and education. Through strategic partnerships with prominent local, regional, and international institutions, the hospital is dedicated to advancing medical technologies and elevating the standards of healthcare worldwide.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, “Brand Finance” ranked King Faisal Specialist Hospital & Research Centre as the top Academic Medical Centre in the Middle East and Africa, and among the top 20 globally. Additionally, in 2024, it was recognized as one of the World's Best Hospitals by Newsweek magazine, and ranked # 1 in KSA.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non–profit, government–owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

CONTACT INFORMATION

For more information, please contact:

Mr. Essam Al–Zahrani, Media Affairs Acting Head, 0555254429

Mr. Abdullah Al–Awn, Senior Media Editor, 0556294232

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c4299c01–0079–498b–8350–bd085d769150


GLOBENEWSWIRE (Distribution ID 9078638)